Deep Brain Stimulation for Obsessive-compulsive Disorder
Key facts
- Who runs it
- Umeå University
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 26 people, planned
- Started
- 11 Sept 2018
- Expected to end
- 31 Dec 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Deep brain stimulation
- Record updated
- 17 October 2024
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- OCD diagnosed according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
- The patients should have received at least 16 sessions of cognitive behavioral therapy, tried three different serotonergic antidepressants in adequate doses for three months, and one serotonergic antidepressant in combination with a neuroleptic drug
- Severe OCD symptoms: YBOCS ≥ 25 points
- Substantial incapacity because of his/her symptoms
- Duration of symptoms: 5 years minimum
- Understand the consequences of participation in the study and give informed written consent
Who cannot take part
- Not being able to understand the consequences of the treatment
- Diagnosed with intellectual disability according to DSM-IV
- Not meeting the requirements for the neurosurgery procedure
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Obsessive-compulsive disorder
This trial is currently available in Sweden.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate the treatment method of deep brain stimulation (DBS) in patients diagnosed with severe and treatment-resistant obsessive-compulsive disorder (OCD). DBS will be administered into the brain area of the bed nucleus of stria terminalis (BNST).
Read full original descriptionShow less
The main research questions are:
* Does active DBS in BNST reduce OCD symptoms (primary outcome)? * Does active DBS in BNST reduce anxiety or depressive symptoms and improve the level of daily function?
The participants will be randomized to active or sham DBS in the BNST for six months and we will measure the outcomes before DBS surgery, and six months post-surgery. After the randomization phase, the participants will enter an open-label phase and receive continuous DBS in BNST. Yearly follow-ups will be conducted. The outcomes will be measured through interviews using validated psychometric scales.
The 2 groups in the trial
- Active stimulationExisting treatment, for comparison
Deep brain stimulation - active stimulation
Treatment: Deep brain stimulation
- Sham stimulationSham treatment, for comparison
Deep brain stimulation - no stimulation
Treatment: Deep brain stimulation
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Deep Brain Stimulation for the Treatment of Severe Obsessive-compulsive Disorder
- Criteria questions
- Built from NCT06628752, who can take part
- Record updated
- 17 October 2024